<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33244084</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Empty mesoporous silica particles significantly delay disease progression and extend survival in a mouse model of ALS.</ArticleTitle><Pagination><StartPage>20675</StartPage><MedlinePgn>20675</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20675</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-77578-x</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating incurable neurological disorder characterized by motor neuron (MN) death and muscle dysfunction leading to mean survival time after diagnosis of only 2-5&#xa0;years. A potential ALS treatment is to delay the loss of MNs and disease progression by the delivery of trophic factors. Previously, we demonstrated that implanted mesoporous silica nanoparticles (MSPs) loaded with trophic factor peptide mimetics support survival and induce differentiation of co-implanted embryonic stem cell (ESC)-derived MNs. Here, we investigate whether MSP loaded with peptide mimetics of ciliary neurotrophic factor (Cintrofin), glial-derived neurotrophic factor (Gliafin), and vascular endothelial growth factor (Vefin1) injected into the cervical spinal cord of mutant SOD1 mice affect disease progression and extend survival. We also transplanted boundary cap neural crest stem cells (bNCSCs) which have been shown previously to have a positive effect on MN survival in vitro and in vivo. We show that mimetic-loaded MSPs and bNCSCs significantly delay disease progression and increase survival of mutant SOD1 mice, and also that empty particles significantly improve the condition of ALS mice. Our results suggest that intraspinal delivery of MSPs is a potential therapeutic approach for the treatment of ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leyton-Jaimes</LastName><ForeName>Marcel F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Zlotowski Center for Neuroscience, Faculty of Health Sciences, Ben-Gurion University of the Negev, P.O.B. 653, 84105, Beer Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ivert</LastName><ForeName>Patrik</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Regenerative Neurobiology, Uppsala University Biomedical Center, Box 593, 751 24, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoeber</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Regenerative Neurobiology, Uppsala University Biomedical Center, Box 593, 751 24, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Box 815, 751 08, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Yilin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Regenerative Neurobiology, Uppsala University Biomedical Center, Box 593, 751 24, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feiler</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nanologica AB, Forskargatan 20G, 151 36, S&#xf6;dert&#xe4;lje, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chemistry Department, KTH, Royal Institute of Technology, 100 44, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Chunfang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Chemistry Department, KTH, Royal Institute of Technology, 100 44, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pankratova</LastName><ForeName>Stanislava</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Laboratory of Neural Plasticity, Department of Neuroscience, University of Copenhagen, 2200, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Comparative Pediatrics and Nutrition, Department of Veterinary and Animal Sciences, University of Copenhagen, 1870, Frederiksberg C, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoshan-Barmatz</LastName><ForeName>Varda</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, The National Institute for Biotechnology in the Negev Ltd, Ben-Gurion University of the Negev, 84105, Beer Sheva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Israelson</LastName><ForeName>Adrian</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physiology and Cell Biology, Zlotowski Center for Neuroscience, Faculty of Health Sciences, Ben-Gurion University of the Negev, P.O.B. 653, 84105, Beer Sheva, Israel. adriani@bgu.ac.il.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozlova</LastName><ForeName>Elena N</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Regenerative Neurobiology, Uppsala University Biomedical Center, Box 593, 751 24, Uppsala, Sweden. elena.kozlova@neuro.uu.se.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051100">Glial Cell Line-Derived Neurotrophic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042461">Vascular Endothelial Growth Factor A</NameOfSubstance></Chemical><Chemical><RegistryNumber>7631-86-9</RegistryNumber><NameOfSubstance UI="D012822">Silicon Dioxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066193" MajorTopicYN="N">Cervical Cord</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053595" MajorTopicYN="N">Embryonic Stem Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051100" MajorTopicYN="N">Glial Cell Line-Derived Neurotrophic Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009432" MajorTopicYN="N">Neural Crest</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058953" MajorTopicYN="N">Neural Stem Cells</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012822" MajorTopicYN="N">Silicon Dioxide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042461" MajorTopicYN="N">Vascular Endothelial Growth Factor A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>27</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33244084</ArticleId><ArticleId IdType="pmc">PMC7691331</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-77578-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-77578-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Taylor JP, Brown RH, Cleveland DW. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamez J, et al. Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: Should all sporadic ALS cases also be screened for SOD1? J. Neurol. Sci. 2006;247:21&#x2013;28. doi: 10.1016/j.jns.2006.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.03.006</ArticleId><ArticleId IdType="pubmed">16674979</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn LI, et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18:327&#x2013;338. doi: 10.1016/S0896-6273(00)80272-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(00)80272-X</ArticleId><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, et al. Copper-binding-site-null SOD1 causes ALS in transgenic mice: Aggregates of non-native SOD1 delineate a common feature. Hum. Mol. Genet. 2003;12:2753&#x2013;2764. doi: 10.1093/hmg/ddg312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddg312</ArticleId><ArticleId IdType="pubmed">12966034</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong PC, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995;14:1105&#x2013;1116. doi: 10.1016/0896-6273(95)90259-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(95)90259-7</ArticleId><ArticleId IdType="pubmed">7605627</ArticleId></ArticleIdList></Reference><Reference><Citation>Howland DS, et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) Proc. Natl. Acad. Sci. USA. 2002;99:1604&#x2013;1609. doi: 10.1073/pnas.032539299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.032539299</ArticleId><ArticleId IdType="pmc">PMC122237</ArticleId><ArticleId IdType="pubmed">11818550</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, et al. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: Associated mutations develop motor neuron disease. J. Neurosci. 2001;21:9246&#x2013;9254. doi: 10.1523/JNEUROSCI.21-23-09246.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-23-09246.2001</ArticleId><ArticleId IdType="pmc">PMC6763929</ArticleId><ArticleId IdType="pubmed">11717358</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerman A, et al. Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form. Acta Neuropathol. 2010;119:335&#x2013;344. doi: 10.1007/s00401-010-0646-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-010-0646-5</ArticleId><ArticleId IdType="pubmed">20111867</ArticleId></ArticleIdList></Reference><Reference><Citation>Verghese J, et al. Motoric cognitive risk syndrome Multicountry prevalence and dementia risk. Neurology. 2014;83:718&#x2013;726. doi: 10.1212/WNL.0000000000000717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000717</ArticleId><ArticleId IdType="pmc">PMC4150127</ArticleId><ArticleId IdType="pubmed">25031288</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S, et al. Misfolded SOD1 is not a primary component of sporadic ALS. Acta Neuropathol. 2017;134:97&#x2013;111. doi: 10.1007/s00401-017-1688-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1688-8</ArticleId><ArticleId IdType="pmc">PMC5472502</ArticleId><ArticleId IdType="pubmed">28247063</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco DA, et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 2010;13:1396&#x2013;1403. doi: 10.1038/nn.2660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2660</ArticleId><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsberg Z, et al. Cleavage of cellulose by a cbm33 protein. Protein Sci. 2011;20:1479&#x2013;1483. doi: 10.1002/pro.689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.689</ArticleId><ArticleId IdType="pmc">PMC3190143</ArticleId><ArticleId IdType="pubmed">21748815</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterstr&#xf6;m P, Graffmo KS, Andersen PM, Br&#xe4;nnstr&#xf6;m T, Marklund SL. Proteins that bind to misfolded mutant superoxide dismutase-1 in spinal cords from transgenic amyotrophic lateral sclerosis (ALS) model mice. J. Biol. Chem. 2011;286:20130&#x2013;20136. doi: 10.1074/jbc.M111.218842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.218842</ArticleId><ArticleId IdType="pmc">PMC3121531</ArticleId><ArticleId IdType="pubmed">21493711</ArticleId></ArticleIdList></Reference><Reference><Citation>Guareschi S, et al. An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc. Natl. Acad. Sci. USA. 2012;109:5074&#x2013;5079. doi: 10.1073/pnas.1115402109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1115402109</ArticleId><ArticleId IdType="pmc">PMC3324021</ArticleId><ArticleId IdType="pubmed">22416121</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, et al. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and-independent mechanisms. Proc. Natl. Acad. Sci. 2014;111:3620&#x2013;3625. doi: 10.1073/pnas.1312245111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Par&#xe9; B, et al. Misfolded SOD1 pathology in sporadic amyotrophic lateral sclerosis. Sci. Rep. 2018;8:1&#x2013;13. doi: 10.1038/s41598-018-31773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31773-z</ArticleId><ArticleId IdType="pmc">PMC6155098</ArticleId><ArticleId IdType="pubmed">30242181</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouel F, Rolland AS, Devedjian JC, Burnouf T, Devos D. Past and future of neurotrophic growth factors therapies in ALS: From single neurotrophic growth factor to stem cells and human platelet lysates. Front. Neurol. 2019;10:835&#x2013;835. doi: 10.3389/fneur.2019.00835.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00835</ArticleId><ArticleId IdType="pmc">PMC6688198</ArticleId><ArticleId IdType="pubmed">31428042</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallet-Reg&#xed; M, Colilla M, Izquierdo-Barba I, Manzano M. Mesoporous silica nanoparticles for drug delivery: Current insights. Molecules. 2018;23:47. doi: 10.3390/molecules23010047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23010047</ArticleId><ArticleId IdType="pmc">PMC5943960</ArticleId><ArticleId IdType="pubmed">29295564</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Zhang Y, Feng N. Mesoporous silica nanoparticles: Synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery. Expert Opin. Drug Deliv. 2019;16:219&#x2013;237. doi: 10.1080/17425247.2019.1575806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17425247.2019.1575806</ArticleId><ArticleId IdType="pubmed">30686075</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Bennett AE, et al. In vitro generation of motor neuron precursors from mouse embryonic stem cells using mesoporous nanoparticles. Nanomedicine. 2014;9:2457&#x2013;2466. doi: 10.2217/nnm.14.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nnm.14.23</ArticleId><ArticleId IdType="pubmed">24661257</ArticleId></ArticleIdList></Reference><Reference><Citation>22Garcia-Bennett, A. E. &amp; Kozlova, E. N. Method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmceutical active ingredients. United States patent 13/808,809 (2013).</Citation></Reference><Reference><Citation>Hoeber J, et al. A combinatorial approach to induce sensory axon regeneration into the dorsal root avulsed spinal cord. Stem Cells Dev. 2017;26:1065&#x2013;1077. doi: 10.1089/scd.2017.0019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2017.0019</ArticleId><ArticleId IdType="pubmed">28562227</ArticleId></ArticleIdList></Reference><Reference><Citation>Abati E, Bresolin N, Comi GP, Corti S. Preconditioning and cellular engineering to increase the survival of transplanted neural stem cells for motor neuron disease therapy. Mol. Neurobiol. 2019;56:3356&#x2013;3367. doi: 10.1007/s12035-018-1305-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1305-4</ArticleId><ArticleId IdType="pubmed">30120734</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalfa C, Azmoon P, Mantuano E, Gonias SL. Tissue-type plasminogen activator neutralizes LPS but not protease-activated receptor-mediated inflammatory responses to plasmin. J. Leukoc. Biol. 2019;105:729&#x2013;740. doi: 10.1002/JLB.3A0818-329RRR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3A0818-329RRR</ArticleId><ArticleId IdType="pmc">PMC6430673</ArticleId><ArticleId IdType="pubmed">30690783</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman SA, et al. Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS. Ann. Clin. Transl. Neurol. 2018;5:730&#x2013;740. doi: 10.1002/acn3.567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.567</ArticleId><ArticleId IdType="pmc">PMC5989736</ArticleId><ArticleId IdType="pubmed">29928656</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L, et al. Results from phase I clinical trial with intraspinal injection of neural stem cells in amyotrophic lateral sclerosis: A long-term outcome. Stem Cells Transl. Med. 2019;8:887&#x2013;897. doi: 10.1002/sctm.18-0154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.18-0154</ArticleId><ArticleId IdType="pmc">PMC6708070</ArticleId><ArticleId IdType="pubmed">31104357</ArticleId></ArticleIdList></Reference><Reference><Citation>Olerud J, et al. Neural crest stem cells increase beta cell proliferation and improve islet function in co-transplanted murine pancreatic islets. Diabetologia. 2010;52:2594&#x2013;2601. doi: 10.1007/s00125-009-1544-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-009-1544-z</ArticleId><ArticleId IdType="pubmed">19823803</ArticleId></ArticleIdList></Reference><Reference><Citation>Grouwels G, et al. Differentiating neural crest stem cells induce proliferation of cultured rodent islet beta cells. Diabetologia. 2012;55:2016&#x2013;2025. doi: 10.1007/s00125-012-2542-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-012-2542-0</ArticleId><ArticleId IdType="pubmed">22618811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngamjariyawat A, Turpaev K, Vasylovska S, Kozlova EN, Welsh N. Co-culture of neural crest stem cells (NCSC) and insulin producing beta-TC6 cells results in cadherin junctions and protection against cytokine-induced beta-cell death. PLoS ONE. 2013;8:e61828&#x2013;e61828. doi: 10.1371/journal.pone.0061828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0061828</ArticleId><ArticleId IdType="pmc">PMC3629122</ArticleId><ArticleId IdType="pubmed">23613946</ArticleId></ArticleIdList></Reference><Reference><Citation>Grapensparr L, et al. Co-transplantation of human pancreatic islets with post-migratory neural crest stem cells increases &#x3b2;-cell proliferation and vascular and neural regrowth. J. Clin. Endocrinol. Metab. 2015;100:E583&#x2013;E590. doi: 10.1210/jc.2014-4070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2014-4070</ArticleId><ArticleId IdType="pubmed">25668197</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizas N, et al. Neural crest stem cells protect spinal cord neurons from excitotoxic damage and inhibit glial activation by secretion of brain-derived neurotrophic factor. Cell Tissue Res. 2018;372:493&#x2013;505. doi: 10.1007/s00441-018-2808-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-018-2808-z</ArticleId><ArticleId IdType="pmc">PMC5949140</ArticleId><ArticleId IdType="pubmed">29516218</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal T, Hoeber J, Ivert P, Vasylovska S, Kozlova EN. Boundary cap neural crest stem cells promote survival of mutant SOD1 motor neurons. Neurotherapeutics. 2017;14:773&#x2013;783. doi: 10.1007/s13311-016-0505-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-016-0505-8</ArticleId><ArticleId IdType="pmc">PMC5509618</ArticleId><ArticleId IdType="pubmed">28070746</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Bennett AE, et al. Delivery of differentiation factors by mesoporous silica particles assists advanced differentiation of transplanted murine embryonic stem cells. Stem Cells Transl. Med. 2013;2:906&#x2013;915. doi: 10.5966/sctm.2013-0072.</Citation><ArticleIdList><ArticleId IdType="doi">10.5966/sctm.2013-0072</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamas-Ardisana PJ, et al. Disposable amperometric biosensor based on lactate oxidase immobilised on platinum nanoparticle-decorated carbon nanofiber and poly(diallyldimethylammonium chloride) films. Biosens. Bioelectron. 2014;56:345&#x2013;351. doi: 10.1016/j.bios.2014.01.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bios.2014.01.047</ArticleId><ArticleId IdType="pubmed">24534552</ArticleId></ArticleIdList></Reference><Reference><Citation>Islamov RR, et al. Tandem delivery of multiple therapeutic genes using umbilical cord blood cells improves symptomatic outcomes in ALS. Mol. Neurobiol. 2017;54:4756&#x2013;4763. doi: 10.1007/s12035-016-0017-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0017-x</ArticleId><ArticleId IdType="pubmed">27495938</ArticleId></ArticleIdList></Reference><Reference><Citation>Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde YA. Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature. 1992;360:757&#x2013;759. doi: 10.1038/360757a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/360757a0</ArticleId><ArticleId IdType="pubmed">1465147</ArticleId></ArticleIdList></Reference><Reference><Citation>Tovar-y-Romo LB, Ram&#xed;rez-Jarqu&#xed;n UN, Lazo-G&#xf3;mez R, Tapia R. Trophic factors as modulators of motor neuron physiology and survival: Implications for ALS therapy. Front. Cell. Neurosci. 2014;8:61&#x2013;61. doi: 10.3389/fncel.2014.00061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00061</ArticleId><ArticleId IdType="pmc">PMC3937589</ArticleId><ArticleId IdType="pubmed">24616665</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayalakshmi K, et al. Role of VEGF and VEGFR2 receptor in reversal of ALS-CSF induced degeneration of NSC-34 motor neuron cell line. Mol. Neurobiol. 2015;51:995&#x2013;1007. doi: 10.1007/s12035-014-8757-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8757-y</ArticleId><ArticleId IdType="pubmed">24880751</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M, et al. Transplanted modified muscle progenitor cells expressing a mixture of neurotrophic factors delay disease onset and enhance survival in the SOD1 mouse model of ALS. J. Mol. Neurosci. 2014;55:788&#x2013;797. doi: 10.1007/s12031-014-0426-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-014-0426-0</ArticleId><ArticleId IdType="pubmed">25330859</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen J, et al. Role of glial cell line-derived neurotrophic factor (GDNF)&#x2013;neural cell adhesion molecule (NCAM) interactions in induction of neurite outgrowth and identification of a binding site for NCAM in the heel region of GDNF. J. Neurosci. 2009;29:11360&#x2013;11376. doi: 10.1523/JNEUROSCI.3239-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3239-09</ArticleId><ArticleId IdType="pmc">PMC6665939</ArticleId><ArticleId IdType="pubmed">19741142</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathje M, et al. A peptide derived from the CD loop-D helix region of ciliary neurotrophic factor (CNTF) induces neuronal differentiation and survival by binding to the leukemia inhibitory factor (LIF) receptor and common cytokine receptor chain gp130. Eur. J. Cell Biol. 2011;90:990&#x2013;999. doi: 10.1016/j.ejcb.2011.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcb.2011.08.001</ArticleId><ArticleId IdType="pubmed">22000729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C, Nennesmo I, Fadeel B, Henter JI. Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 2004;56:564&#x2013;567. doi: 10.1002/ana.20223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20223</ArticleId><ArticleId IdType="pubmed">15389897</ArticleId></ArticleIdList></Reference><Reference><Citation>Dmytriyeva O, et al. Neurotrophic effects of vascular endothelial growth factor B and novel mimetic peptides on neurons from the central nervous system. ACS Chem. Neurosci. 2020;11:1270&#x2013;1282. doi: 10.1021/acschemneuro.9b00685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.9b00685</ArticleId><ArticleId IdType="pubmed">32283014</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L, et al. Potential role of gut microbiota in ALS pathogenesis and possible novel therapeutic strategies. J. Clin. Gastroenterol. 2018;52:S68&#x2013;S70. doi: 10.1097/MCG.0000000000001042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCG.0000000000001042</ArticleId><ArticleId IdType="pubmed">29782468</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman SA, et al. High plasma concentrations of organic pollutants negatively impact survival in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2019;90:907&#x2013;912. doi: 10.1136/jnnp-2018-319785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319785</ArticleId><ArticleId IdType="pmc">PMC6625908</ArticleId><ArticleId IdType="pubmed">30760645</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalfa C, et al. Transplantation of clinical-grade human neural stem cells reduces neuroinflammation, prolongs survival and delays disease progression in the SOD1 rats. Cell Death Dis. 2019;10:1&#x2013;15. doi: 10.1038/s41419-019-1582-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1582-5</ArticleId><ArticleId IdType="pmc">PMC6484011</ArticleId><ArticleId IdType="pubmed">31024007</ArticleId></ArticleIdList></Reference><Reference><Citation>Trolle C, Konig N, Abrahamsson N, Vasylovska S, Kozlova EN. Boundary cap neural crest stem cells homotopically implanted to the injured dorsal root transitional zone give rise to different types of neurons and glia in adult rodents. BMC Neurosci. 2014;15:60&#x2013;60. doi: 10.1186/1471-2202-15-60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2202-15-60</ArticleId><ArticleId IdType="pmc">PMC4055944</ArticleId><ArticleId IdType="pubmed">24884373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers, J. I. &amp; Cashman, N. R. in Handbook of Clinical Neurology Vol. 153 (ed Quinn, T. Ostrom) 337&#x2013;354 (Elsevier, Amsterdam, 2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29887144</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M, Cleveland DW. Biological spectrum of amyotrophic lateral sclerosis prions. Cold Spring Harb. Perspect. Med. 2017;7:a024133. doi: 10.1101/cshperspect.a024133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024133</ArticleId><ArticleId IdType="pmc">PMC5666626</ArticleId><ArticleId IdType="pubmed">28062558</ArticleId></ArticleIdList></Reference><Reference><Citation>Besse B, et al. Hyperprogressive disease in patients with advanced non-small cell lung cancer treated with PD-1/PD-L1 inhibitors or with single-agent chemotherapy. JAMA Oncol. 2018;4:1543&#x2013;1552. doi: 10.1001/jamaoncol.2018.3676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaoncol.2018.3676</ArticleId><ArticleId IdType="pmc">PMC6248085</ArticleId><ArticleId IdType="pubmed">30193240</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman JM, et al. Disease mechanisms in ALS: Misfolded SOD1 transferred through exosome-dependent and exosome-independent pathways. Cell Mol. Neurobiol. 2016;36:377&#x2013;381. doi: 10.1007/s10571-015-0294-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-015-0294-3</ArticleId><ArticleId IdType="pubmed">26908139</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara D, Pasetto L, Bonetto V, Basso M. Role of extracellular vesicles in amyotrophic lateral sclerosis. Front. Neurosci. 2018;12:574. doi: 10.3389/fnins.2018.00574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00574</ArticleId><ArticleId IdType="pmc">PMC6107782</ArticleId><ArticleId IdType="pubmed">30174585</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A, et al. Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1. Neuron. 2015;86:218&#x2013;232. doi: 10.1016/j.neuron.2015.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.02.034</ArticleId><ArticleId IdType="pmc">PMC4393372</ArticleId><ArticleId IdType="pubmed">25801706</ArticleId></ArticleIdList></Reference><Reference><Citation>Israelson A, et al. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron. 2010;67:575&#x2013;587. doi: 10.1016/j.neuron.2010.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.07.019</ArticleId><ArticleId IdType="pmc">PMC2941987</ArticleId><ArticleId IdType="pubmed">20797535</ArticleId></ArticleIdList></Reference><Reference><Citation>Shteinfer-Kuzmine A, et al. A VDAC1-derived N-terminal peptide inhibits mutant SOD1-VDAC1 interactions and toxicity in the SOD1 model of ALS. Front Cell Neurosci. 2019;13:346. doi: 10.3389/fncel.2019.00346.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00346</ArticleId><ArticleId IdType="pmc">PMC6702328</ArticleId><ArticleId IdType="pubmed">31474832</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishitoh H, et al. ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1. Genes Dev. 2008;22:1451&#x2013;1464. doi: 10.1101/gad.1640108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1640108</ArticleId><ArticleId IdType="pmc">PMC2418582</ArticleId><ArticleId IdType="pubmed">18519638</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Appel SH. Immune dysregulation in amyotrophic lateral sclerosis: Mechanisms and emerging therapies. Lancet Neurol. 2019;18:211&#x2013;220. doi: 10.1016/S1474-4422(18)30394-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30394-6</ArticleId><ArticleId IdType="pubmed">30663610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa M. Mesoporous silica layer: Preparation and opportunity. Chem. Rec. 2017;17:217&#x2013;232. doi: 10.1002/tcr.201600068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/tcr.201600068</ArticleId><ArticleId IdType="pubmed">27524247</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Bennett AE. Synthesis, toxicology and potential of ordered mesoporous materials in nanomedicine. Nanomedicine. 2011;6:867&#x2013;877. doi: 10.2217/nnm.11.82.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nnm.11.82</ArticleId><ArticleId IdType="pubmed">21793677</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichterle H, Lieberam I, Porter JA, Jessell TM. Directed differentiation of embryonic stem cells into motor neurons. Cell. 2002;110:385&#x2013;397. doi: 10.1016/s0092-8674(02)00835-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(02)00835-8</ArticleId><ArticleId IdType="pubmed">12176325</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacquier A, Risson V, Schaeffer L. Modeling Charcot&#x2013;Marie&#x2013;Tooth disease in vitro by transfecting mouse primary motoneurons. J. Vis. Exp. 2019 doi: 10.3791/57988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/57988</ArticleId><ArticleId IdType="pubmed">30663652</ArticleId></ArticleIdList></Reference><Reference><Citation>Vintersten K, et al. Mouse in red: Red fluorescent protein expression in mouse ES cells, embryos, and adult animals. Genesis. 2004;40:241&#x2013;246. doi: 10.1002/gene.20095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gene.20095</ArticleId><ArticleId IdType="pubmed">15593332</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldskogius H, et al. Regulation of boundary cap neural crest stem cell differentiation after transplantation. Stem Cells. 2009;27:1592&#x2013;1603. doi: 10.1002/stem.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.77</ArticleId><ArticleId IdType="pmc">PMC2733376</ArticleId><ArticleId IdType="pubmed">19544468</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerling-Leffler J, et al. The boundary cap: A source of neural crest stem cells that generate multiple sensory neuron subtypes. Development. 2005;132:2623&#x2013;2632. doi: 10.1242/dev.01852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.01852</ArticleId><ArticleId IdType="pubmed">15872002</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyton-Jaimes MF, Kahn J, Israelson A. AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS. Proc. Natl. Acad. Sci. USA. 2019;116:14755&#x2013;14760. doi: 10.1073/pnas.1904665116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1904665116</ArticleId><ArticleId IdType="pmc">PMC6642395</ArticleId><ArticleId IdType="pubmed">31262807</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>